APOE ɛ4 carrier status has been shown to lead to a high incidence of AD [49] and DLB [50], but the effect of APOE ɛ4 on the risk of dementia and mortality diminishes or disappears with advanced age [51, 52]. This evidence concerns the gene APOE and Lewy body dementia.